Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation

Parodi, 2017, Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery, Biomaterials, 147, 155, 10.1016/j.biomaterials.2017.09.020 Yong, 2020, Extracellular vesicles for tumor targeting delivery based on five features principle, J. Control. Release, 322, 555, 10.1016/j.jconrel.2020.03.039 Srivastava, 2020, Progress in extracellular vesicle biology and their application in cancer medicine, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., e1621, 10.1002/wnan.1621 Stevic, 2020, Monitoring therapy efficiency in Cancer through extracellular vesicles, Cells, 9, 10.3390/cells9010130 Farooqi, 2018, Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds, Biotechnol. Adv., 36, 328, 10.1016/j.biotechadv.2017.12.010 Batista, 2019, Exosomes and the future of immunotherapy in pancreatic Cancer, Int. J. Mol. Sci., 20, 10.3390/ijms20030567 Trams, 1981, Exfoliation of membrane ecto-enzymes in the form of micro-vesicles, Biochimica et Biophysica Acta (BBA) - Biomembranes, 645, 63, 10.1016/0005-2736(81)90512-5 Trams, 1981, Exfoliation of membrane ecto-enzymes in the form of micro-vesicles, Biochimica et Biophysica Acta (BBA) - Biomembranes, 645, 63, 10.1016/0005-2736(81)90512-5 Harding, 1984, Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding, Eur. J. Cell Biol., 35, 256 Johnstone, 1992, Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins, Biochem. Cell Biol., 70, 179, 10.1139/o92-028 Raposo, 1996, B lymphocytes secrete antigen-presenting vesicles, J. Exp. Med., 183, 1161, 10.1084/jem.183.3.1161 Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9, 654, 10.1038/ncb1596 Fitzgerald, 2018, A system of cytokines encapsulated in ExtraCellular vesicles, Sci. Rep., 8, 8973, 10.1038/s41598-018-27190-x Ratajczak, 2006, Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication, Leukemia, 20, 1487, 10.1038/sj.leu.2404296 Thakur, 2014, Double-stranded DNA in exosomes: a novel biomarker in cancer detection, Cell Res., 24, 766, 10.1038/cr.2014.44 Jeppesen, 2019, Reassessment of exosome composition, Cell, 177, 428, 10.1016/j.cell.2019.02.029 Takahashi, 2017, Exosomes maintain cellular homeostasis by excreting harmful DNA from cells, Nat. Commun., 8, 15287, 10.1038/ncomms15287 Vagner, 2018, Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma, J. Extracell. Vesicles, 7, 1505403, 10.1080/20013078.2018.1505403 Zhang, 2018, MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity, Biomaterials, 156, 16, 10.1016/j.biomaterials.2017.11.028 Alexander, 2015, Exosome-delivered microRNAs modulate the inflammatory response to endotoxin, Nat. Commun., 6, 7321, 10.1038/ncomms8321 Nanbo, 2013, Exosomes derived from epstein-barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells, J. Virol., 87, 10334, 10.1128/JVI.01310-13 Han, 2019, Extracellular vesicles in the tumor microenvironment: old stories, but new tales, Mol. Cancer, 18, 59, 10.1186/s12943-019-0980-8 Lucchetti, 2020, Extracellular vesicles and Cancer: a focus on metabolism, cytokines, and immunity, Cancers (Basel), 12, 10.3390/cancers12010171 Jurj, 2020, A comprehensive picture of extracellular vesicles and their contents, Molecular Transfer to Cancer Cells. Cancers (Basel), 12 Yáñez-Mó, 2015, Biological properties of extracellular vesicles and their physiological functions, J. Extracell. Vesicles, 4, 27066, 10.3402/jev.v4.27066 Patel, 2017, Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles, Bioeng. Transl. Med., 2, 170, 10.1002/btm2.10065 Palviainen, 2019, Metabolic signature of extracellular vesicles depends on the cell culture conditions, J. Extracell. Vesicles, 8, 1596669, 10.1080/20013078.2019.1596669 Johnsen, 2018, On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems - A commentary, J. Control. Release, 269, 10, 10.1016/j.jconrel.2017.11.002 Willms, 2018, Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in Cancer progression, Front. Immunol., 9, 738, 10.3389/fimmu.2018.00738 Théry, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell. Vesicles, 7, 1535750, 10.1080/20013078.2018.1535750 Skotland, 2017, Lipids in exosomes: current knowledge and the way forward, Prog. Lipid Res., 66, 30, 10.1016/j.plipres.2017.03.001 Wu, 2019, Profiling surface proteins on individual exosomes using a proximity barcoding assay, Nat. Commun., 10, 3854, 10.1038/s41467-019-11486-1 Li, 2017, Exosomal proteins as potential markers of tumor diagnosis, J. Hematol. Oncol., 10, 175, 10.1186/s13045-017-0542-8 Carayon, 2011, Proteolipidic composition of exosomes changes during reticulocyte maturation, J. Biol. Chem., 286, 34426, 10.1074/jbc.M111.257444 Zhang, 2019, Exosomes: biogenesis, biologic function and clinical potential, Cell Biosci., 9, 19, 10.1186/s13578-019-0282-2 Sharma, 2017, Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies, Br. J. Cancer, 117, 545, 10.1038/bjc.2017.183 Miyanishi, 2007, Identification of Tim4 as a phosphatidylserine receptor, Nature, 450, 435, 10.1038/nature06307 Matsumoto, 2017, Role of phosphatidylserine-derived negative surface charges in the recognition and uptake of intravenously injected B16BL6-Derived exosomes by macrophages, J. Pharm. Sci., 106, 168, 10.1016/j.xphs.2016.07.022 Weiskopf, 2017, Cancer immunotherapy targeting the CD47/SIRPalpha axis, Eur. J. Cancer, 76, 100, 10.1016/j.ejca.2017.02.013 Koh, 2017, Exosome-SIRPalpha, a CD47 blockade increases cancer cell phagocytosis, Biomaterials, 121, 121, 10.1016/j.biomaterials.2017.01.004 Kamerkar, 2017, Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer, Nature, 546, 498, 10.1038/nature22341 Zhang, 2019, Artificial chimeric exosomes for anti-phagocytosis and targeted cancer therapy, Chem. Sci., 10, 1555, 10.1039/C8SC03224F Andreu, 2014, Tetraspanins in extracellular vesicle formation and function, Front. Immunol., 5 Lee, 2018, Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles, BMC Cancer, 18, 1058, 10.1186/s12885-018-4952-y Yoshioka, 2013, Comparative marker analysis of extracellular vesicles in different human cancer types, J. Extracell. Vesicles, 2, 20424, 10.3402/jev.v2i0.20424 Vogt, 2018, Stabilization of the CD81 large extracellular loop with de novo disulfide bonds improves its amenability for peptide grafting, Pharmaceutics, 10, 10.3390/pharmaceutics10030138 Rana, 2012, Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection, Int. J. Biochem. Cell Biol., 44, 1574, 10.1016/j.biocel.2012.06.018 Laulagnier, 2018, Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons, Cell. Mol. Life Sci., 75, 757, 10.1007/s00018-017-2664-0 Charoenviriyakul, 2018, Role of extracellular vesicle surface proteins in the pharmacokinetics of extracellular vesicles, Mol. Pharm., 15, 1073, 10.1021/acs.molpharmaceut.7b00950 Li, 2019, Challenges and opportunities in exosome research-Perspectives from biology, engineering, and cancer therapy, APL Bioeng, 3, 011503, 10.1063/1.5087122 Freitas, 2019, Different isolation approaches lead to diverse glycosylated extracellular vesicle populations, J. Extracell. Vesicles, 8, 1621131, 10.1080/20013078.2019.1621131 Varga, 2014, Towards traceable size determination of extracellular vesicles, J. Extracell. Vesicles, 3, 23298, 10.3402/jev.v3.23298 Patel, 2019, Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications, Sci. Rep., 9, 5335, 10.1038/s41598-019-41800-2 Coumans Frank, 2017, Methodological guidelines to study extracellular vesicles, Circ. Res., 120, 1632, 10.1161/CIRCRESAHA.117.309417 Ludwig, 2019, Optimization of cell culture conditions for exosome isolation using mini-size exclusion chromatography (mini-SEC), Exp. Cell Res., 378, 149, 10.1016/j.yexcr.2019.03.014 Hong, 2014, Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia, PLoS One, 9, e103310, 10.1371/journal.pone.0103310 Lee, 2019, Considerations and implications in the purification of extracellular vesicles - a cautionary tale, Front. Neurosci., 13, 1067, 10.3389/fnins.2019.01067 Kornilov, 2018, Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum, J. Extracell. Vesicles, 7, 1422674, 10.1080/20013078.2017.1422674 Oeyen, 2018, Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine, J. Extracell. Vesicles, 7, 1490143, 10.1080/20013078.2018.1490143 Lobb, 2015, Optimized exosome isolation protocol for cell culture supernatant and human plasma, J. Extracell. Vesicles, 4, 27031, 10.3402/jev.v4.27031 Somiya, 2018, Biocompatibility of highly purified bovine milk-derived extracellular vesicles, J. Extracell. Vesicles, 7, 1440132, 10.1080/20013078.2018.1440132 Yang, 2018, Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines, J. Mater. Chem. B Mater. Biol. Med., 6, 1312, 10.1039/C7TB03207B Momen-Heravi, 2017, Isolation of extracellular vesicles by ultracentrifugation, Methods Mol. Biol., 1660, 25, 10.1007/978-1-4939-7253-1_3 Deregibus, 2016, Charge-based precipitation of extracellular vesicles, Int. J. Mol. Med., 38, 1359, 10.3892/ijmm.2016.2759 Jeppesen, 2014, Comparative analysis of discrete exosome fractions obtained by differential centrifugation, J. Extracell. Vesicles, 3, 25011, 10.3402/jev.v3.25011 Li, 2018, Cushioned-density gradient ultracentrifugation (C-DGUC): a refined and high performance method for the isolation, characterization, and use of exosomes, Methods Mol. Biol., 1740, 69, 10.1007/978-1-4939-7652-2_7 Navajas, 2019, Serum Exosome Isolation by Size-Exclusion Chromatography for the Discovery and Validation of Preeclampsia-Associated Biomarkers, Methods Mol. Biol., 1959, 39, 10.1007/978-1-4939-9164-8_3 He, 2019, A highly efficient method for isolating urinary exosomes, Int. J. Mol. Med., 43, 83 McNamara, 2018, Large-scale, cross-flow based isolation of highly pure and endocytosis-competent extracellular vesicles, J. Extracell. Vesicles, 7, 1541396, 10.1080/20013078.2018.1541396 Niu, 2017, Polymer-based precipitation preserves biological activities of extracellular vesicles from an endometrial cell line, PLoS One, 12, e0186534, 10.1371/journal.pone.0186534 Yakimchuk, 2015, Exosomes: isolation methods and specific markers, Mater. Methods, 5, 10.13070/mm.en.5.1450 Tauro, 2012, Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes, Methods, 56, 293, 10.1016/j.ymeth.2012.01.002 Zhang, 2018, Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation, Nat. Cell Biol., 20, 332, 10.1038/s41556-018-0040-4 Echevarria, 2014, Microarray-based identification of lectins for the purification of human urinary extracellular vesicles directly from urine samples, Chembiochem, 15, 1621, 10.1002/cbic.201402058 Rezeli, 2016, Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation, Anal. Chem., 88, 8577, 10.1021/acs.analchem.6b01694 Contreras-Naranjo, 2017, Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine, Lab Chip, 17, 3558, 10.1039/C7LC00592J Li, 2017, Progress in exosome isolation techniques, Theranostics, 7, 789, 10.7150/thno.18133 Sokolova, 2011, Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy, Colloids Surf. B Biointerfaces, 87, 146, 10.1016/j.colsurfb.2011.05.013 Narbute, 2019, Intranasal administration of extracellular vesicles derived from human teeth stem cells improves motor symptoms and normalizes tyrosine hydroxylase expression in the Substantia Nigra and striatum of the 6-Hydroxydopamine-Treated rats, Stem Cells Transl. Med., 8, 490, 10.1002/sctm.18-0162 Filipe, 2010, Critical evaluation of Nanoparticle tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates, Pharm. Res., 27, 796, 10.1007/s11095-010-0073-2 Pospichalova, 2015, Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer, J. Extracell. Vesicles, 4, 25530, 10.3402/jev.v4.25530 Kowal, 2017, Extracellular vesicle isolation and analysis by western blotting, Methods Mol. Biol., 1660, 143, 10.1007/978-1-4939-7253-1_12 Chung, 2007, Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes, Arterioscler. Thromb. Vasc. Biol., 27, 414, 10.1161/01.ATV.0000252898.48084.6a Kina, 2000, The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage, Br. J. Haematol., 109, 280, 10.1046/j.1365-2141.2000.02037.x Burnier, 2009, Cell-derived microparticles in haemostasis and vascular medicine, Thromb. Haemost., 101, 439, 10.1160/TH08-08-0521 Wahlund, 2017, Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo, Sci. Rep., 7, 17095, 10.1038/s41598-017-16609-6 Di Trapani, 2016, Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions, Sci. Rep., 6, 24120, 10.1038/srep24120 Canellini, 2012, Red blood cell microparticles and blood group antigens: an analysis by flow cytometry, Blood Transfus., 10, s39 Usman, 2018, Efficient RNA drug delivery using red blood cell extracellular vesicles, Nat. Commun., 9, 2359, 10.1038/s41467-018-04791-8 Baka, 2010, Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis, Immunol. Lett., 128, 124, 10.1016/j.imlet.2009.12.018 Shet, 2003, Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytes, Blood, 102, 2678, 10.1182/blood-2003-03-0693 Tang, 2016, Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-kappaB in endothelial cells, FASEB J., 30, 3097, 10.1096/fj.201600368RR Kumar, 2017, Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury, J. Neuroinflammation, 14, 47, 10.1186/s12974-017-0819-4 Combes, 1999, In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant, J. Clin. Invest., 104, 93, 10.1172/JCI4985 Zhang, 2018, Exosomes derived from human umbilical vein endothelial cells promote neural stem cell expansion while maintain their stemness in culture, Biochem. Biophys. Res. Commun., 495, 892, 10.1016/j.bbrc.2017.11.092 Fauré, 2006, Exosomes are released by cultured cortical neurones, Mol. Cell. Neurosci., 31, 642, 10.1016/j.mcn.2005.12.003 Tian, 2015, Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury, Blood, 125, 2151, 10.1182/blood-2014-09-598805 Heijnen, 1999, Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules, Blood, 94, 3791, 10.1182/blood.V94.11.3791 Ayers, 2014, Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity, J. Extracell. Vesicles, 3, 25348, 10.3402/jev.v3.25348 Tauro, 2013, Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids, Mol. Cell Proteomics, 12, 587, 10.1074/mcp.M112.021303 Kowal, 2016, Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes, Proc. Natl. Acad. Sci., 113, E968, 10.1073/pnas.1521230113 Di Vizio, 2009, Oncosome formation in prostate Cancer: association with a region of frequent chromosomal deletion in metastatic disease, Cancer Res., 69, 5601, 10.1158/0008-5472.CAN-08-3860 Feng, 2010, Cellular internalization of exosomes occurs through phagocytosis, Traffic, 11, 675, 10.1111/j.1600-0854.2010.01041.x Costa Verdera, 2017, Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis, J. Control. Release, 266, 100, 10.1016/j.jconrel.2017.09.019 Wu, 2015, 2nd, Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers, Analyst, 140, 6631, 10.1039/C5AN00688K Mittelbrunn, 2011, Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells, Nat. Commun., 2, 282, 10.1038/ncomms1285 Lai, 2015, Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters, Nat. Commun., 6, 7029, 10.1038/ncomms8029 Kondratov, 2017, A study of extracellular vesicles isolated from blood plasma conducted by low-voltage scanning electron microscopy, Cell tissue biol., 11, 181, 10.1134/S1990519X17030051 Beit-Yannai, 2018, Physical exosome:exosome interactions, J. Cell. Mol. Med., 22, 2001, 10.1111/jcmm.13479 Chernyshev, 2015, Size and shape characterization of hydrated and desiccated exosomes, Anal. Bioanal. Chem., 407, 3285, 10.1007/s00216-015-8535-3 Choi, 2017, Structural analysis of exosomes using different types of Electron microscopy, Appl. Microsc., 47, 171, 10.9729/AM.2017.47.3.171 Cizmar, 2017, Detection and characterization of extracellular vesicles by transmission and cryo-transmission Electron microscopy, Methods Mol. Biol., 1660, 221, 10.1007/978-1-4939-7253-1_18 Morales-Kastresana, 2017, Labeling extracellular vesicles for nanoscale flow cytometry, Sci. Rep., 7, 1878, 10.1038/s41598-017-01731-2 Mantel, 2013, Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system, Cell Host Microbe, 13, 521, 10.1016/j.chom.2013.04.009 Grange, 2014, Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging, Int. J. Mol. Med., 33, 1055, 10.3892/ijmm.2014.1663 Ma, 2014, Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance, Proc Natl Acad Sci U S A, 111, 6389, 10.1073/pnas.1400272111 Li, 2013, PKH26 can transfer to host cells in vitro and vivo, Stem Cells Dev., 22, 340, 10.1089/scd.2012.0357 Roberts-Dalton, 2017, Fluorescence labelling of extracellular vesicles using a novel thiol-based strategy for quantitative analysis of cellular delivery and intracellular traffic, Nanoscale, 9, 10.1039/C7NR04128D Vu, 2019, Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b, J. Extracell. Vesicles, 8, 1599680, 10.1080/20013078.2019.1599680 Triola, 2012, Chemical biology of lipidated proteins, ACS Chem. Biol., 7, 87, 10.1021/cb200460u Zacharias, 2002, Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells, Science, 296, 913, 10.1126/science.1068539 Sung, 2015, Directional cell movement through tissues is controlled by exosome secretion, Nat. Commun., 6, 7164, 10.1038/ncomms8164 Sung, 2019 Gwatkin, 1994, 542 Hoen, 2012, Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles, Nanomed. Nanotechnol. Biol. Med., 8, 712, 10.1016/j.nano.2011.09.006 Crompot, 2015, Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control, PLoS One, 10, e0127209, 10.1371/journal.pone.0127209 Inglis, 2015, Techniques to improve detection and analysis of extracellular vesicles using flow cytometry, Cytometry A., 87, 1052, 10.1002/cyto.a.22649 Van Der Pol, 2012, Single vs. Swarm detection of microparticles and exosomes by flow cytometry, J. Thromb. Haemost., 10, 919, 10.1111/j.1538-7836.2012.04683.x Chandler, 2011, A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer, J. Thromb. Haemost., 9, 1216, 10.1111/j.1538-7836.2011.04283.x Robert, 2009, Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?, J. Thromb. Haemost., 7, 190, 10.1111/j.1538-7836.2008.03200.x Görgens, 2019, Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material, J. Extracell. Vesicles, 8, 10.1080/20013078.2019.1587567 Ender, 2019, Extracellular vesicles: subcellular organelles with the potential to spread Cancer resistance, Anticancer Res., 39, 3395, 10.21873/anticanres.13483 Raimondo, 2020, Extracellular vesicles and tumor-immune escape: biological functions and clinical perspectives, Int. J. Mol. Sci., 21, 10.3390/ijms21072286 Khalil, 2016, The future of cancer treatment: immunomodulation, CARs and combination immunotherapy, Nat. Rev. Clin. Oncol., 13, 273, 10.1038/nrclinonc.2016.25 Parayath, 2020, Extracellular vesicle-mediated nucleic acid transfer and reprogramming in the tumor microenvironment, Cancer Lett., 482, 33, 10.1016/j.canlet.2020.04.009 Gilligan, 2020, Extracellular vesicles for Cancer therapy: impact of host immune response, Cells, 9, 10.3390/cells9010224 Taghikhani, 2020, Engineered tumor-derived extracellular vesicles: potentials in Cancer immunotherapy, Front. Immunol., 11, 221, 10.3389/fimmu.2020.00221 Graner, 2009, Proteomic and immunologic analyses of brain tumor exosomes, Faseb J., 23, 1541, 10.1096/fj.08-122184 Griffiths, 2017, Differential proteome analysis of extracellular vesicles from breast Cancer cell lines by chaperone affinity enrichment, Proteomes, 5, 10.3390/proteomes5040025 Wolfers, 2001, Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming, Nat. Med., 7, 297, 10.1038/85438 Rao, 2016, Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro, Hepatology, 64, 456, 10.1002/hep.28549 Dai, 2008, Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer, Mol. Ther., 16, 782, 10.1038/mt.2008.1 Morishita, 2016, Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA, Biomaterials, 111, 55, 10.1016/j.biomaterials.2016.09.031 Kim, 2017, Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response, Nat. Commun., 8, 626, 10.1038/s41467-017-00729-8 Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Boudreau, 2009, Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity, Mol. Ther., 17, 1465, 10.1038/mt.2009.95 Schadendorf, 2004, Dacarbacine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) as first-line treatment of patients with metastatic melanoma: Results of a prospective-randomized phase III study, J. Clin. Oncol., 22, 10.1200/jco.2004.22.90140.7508 Pitt, 2014, Dendritic cell–Derived exosomes as immunotherapies in the fight against Cancer, J. Immunol., 193, 1006, 10.4049/jimmunol.1400703 Andre, 2004, Exosomes for cancer immunotherapy, Ann. Oncol., 15, iv141, 10.1093/annonc/mdh918 Théry, 2001, Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles, J. Immunol., 166, 7309, 10.4049/jimmunol.166.12.7309 Whiteside, 2017, Stimulatory role of exosomes in the context of therapeutic anti-cancer vaccines, Biotarget, 1, 10.21037/biotarget.2017.05.05 Pollock, 2006, A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke, Exp. Neurol., 199, 143, 10.1016/j.expneurol.2005.12.011 Admyre, 2006, Direct exosome stimulation of peripheral humanT cells detected by ELISPOT, Eur. J. Immunol., 36, 1772, 10.1002/eji.200535615 Muntasell, 2007, T cell-induced secretion of MHC class II–peptide complexes on B cell exosomes, EMBO J., 26, 4263, 10.1038/sj.emboj.7601842 Montecalvo, 2008, Exosomes As a short-range mechanism to spread alloantigen between dendritic cells during t cell allorecognition, J. Immunol., 180, 3081, 10.4049/jimmunol.180.5.3081 Vincent‐Schneider, 2002, Exosomes bearing HLA‐DR1 molecules need dendritic cells to efficiently stimulate specific T cells, Int. Immunol., 14, 713, 10.1093/intimm/dxf048 Théry, 2002, Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes, Nat. Immunol., 3, 1156, 10.1038/ni854 Romagnoli, 2015, Dendritic cell-derived exosomes may be a tool for Cancer immunotherapy by converting tumor cells into immunogenic targets, Front. Immunol., 5 Zitvogel, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes, Nat. Med., 4, 594, 10.1038/nm0598-594 Prado, 2008, Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction, J. Immunol., 181, 1519, 10.4049/jimmunol.181.2.1519 Lamparski, 2002, Production and characterization of clinical grade exosomes derived from dendritic cells, J. Immunol. Methods, 270, 211, 10.1016/S0022-1759(02)00330-7 Escudier, 2005, Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial, J. Transl. Med., 3, 10, 10.1186/1479-5876-3-10 Morse, 2005, A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer, J. Transl. Med., 3, 9, 10.1186/1479-5876-3-9 Besse, 2016, Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC, OncoImmunology, 5, e1071008, 10.1080/2162402X.2015.1071008 Viaud, 2009, Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Rα, PLoS One, 4, e4942, 10.1371/journal.pone.0004942 Lindenbergh, 2018, Antigen presentation by extracellular vesicles from professional antigen-presenting cells, Annu. Rev. Immunol., 36, 435, 10.1146/annurev-immunol-041015-055700 Lu, 2017, Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models, J. Hepatol., 67, 739, 10.1016/j.jhep.2017.05.019 Seddon, 2009, Drug interactions with lipid membranes, Chem. Soc. Rev., 38, 2509, 10.1039/b813853m Tran, 2019, Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs, Pharmaceutics, 11, 10.3390/pharmaceutics11030132 Gwak, 2005, Enhanced bioavailability of piroxicam via salt formation with ethanolamines, Int. J. Pharm., 297, 156 Xiang, 2002, Transbuccal delivery of 2’,3’-dideoxycytidine: in vitro permeation study and histological investigation, Int. J. Pharm., 231, 57, 10.1016/S0378-5173(01)00865-1 McCallion, 2019, Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery, Blood Adv., 3, 2069, 10.1182/bloodadvances.2019000098 Lin, 2017, Quantum Dots-siRNA nanoplexes for gene silencing in central nervous system tumor cells, Front. Pharmacol., 8 Northfelt, 1998, Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi’s sarcoma: results of a randomized phase III clinical trial, J. Clin. Oncol., 16, 2445, 10.1200/JCO.1998.16.7.2445 O’Brien, 2004, Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYXTM/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer, Ann. Oncol., 15, 440, 10.1093/annonc/mdh097 Gill, 1996, Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi’s sarcoma, J. Clin. Oncol., 14, 2353, 10.1200/JCO.1996.14.8.2353 Garay, 2012, Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents, Expert Opin. Drug Deliv., 9, 1319, 10.1517/17425247.2012.720969 Armstrong, 2009, 147 Yang, 2015, Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley interdisciplinary reviews, Nanomedicine and nanobiotechnology, 7, 655, 10.1002/wnan.1339 Ganson, 2016, Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer, J. Allergy Clin. Immunol., 137, 1610, 10.1016/j.jaci.2015.10.034 Povsic, 2016, Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer, J. Allergy Clin. Immunol., 138, 1712, 10.1016/j.jaci.2016.04.058 Uziely, 1995, Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies, J. Clin. Oncol., 13, 1777, 10.1200/JCO.1995.13.7.1777 Chanan-Khan, 2003, Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions, Ann. Oncol., 14, 1430, 10.1093/annonc/mdg374 Cremel, 2013, Red blood cells as innovative antigen carrier to induce specific immune tolerance, Int. J. Pharm., 443, 39, 10.1016/j.ijpharm.2012.12.044 Palomba, 2016, Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability, Sci. Rep., 6, 34422, 10.1038/srep34422 Xuan, 2015, Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo Cancer therapy, Adv. Healthc. Mater., 4, 1645, 10.1002/adhm.201500129 Antimisiaris, 2018, Exosomes and exosome-inspired vesicles for targeted drug delivery, Pharmaceutics, 10, 10.3390/pharmaceutics10040218 Kanchanapally, 2019, Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis, Int. J. Nanomedicine, 14, 531, 10.2147/IJN.S191313 Pullan, 2019, Exosomes as drug carriers for Cancer therapy, Mol. Pharm., 16, 1789, 10.1021/acs.molpharmaceut.9b00104 Tian, 2014, A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, 35, 2383, 10.1016/j.biomaterials.2013.11.083 Munoz, 2013, Delivery of functional Anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity, Mol. Ther. Nucleic Acids, 2, e126, 10.1038/mtna.2013.60 Melzer, 2019, Taxol-loaded MSC-Derived exosomes provide a therapeutic vehicle to target metastatic breast Cancer and other carcinoma cells, Cancers (Basel), 11, 10.3390/cancers11060798 Lee, 2018, pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery, Carbohydr. Polym., 202, 323, 10.1016/j.carbpol.2018.08.141 O’Brien, 2015, miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity, Oncotarget, 6, 10.18632/oncotarget.5192 Donoso-Quezada, 2019, Exosomes as nanocarriers for the delivery of bioactive compounds from black bean extract with antiproliferative activity in cancer cell lines, Mater. Today Proc., 13, 362, 10.1016/j.matpr.2019.03.166 Ohno, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Mol. Ther., 21, 185, 10.1038/mt.2012.180 Osterman, 2015, Curcumin modulates pancreatic adenocarcinoma cell-derived exosomal function, PLoS One, 10, e0132845, 10.1371/journal.pone.0132845 Munagala, 2017, Exosomal formulation of anthocyanidins against multiple cancer types, Cancer Lett., 393, 94, 10.1016/j.canlet.2017.02.004 Aqil, 2017, Exosomal delivery of berry anthocyanidins for the management of ovarian cancer, Food Funct., 8, 4100, 10.1039/C7FO00882A Munagala, 2016, Bovine milk-derived exosomes for drug delivery, Cancer Lett., 371, 48, 10.1016/j.canlet.2015.10.020 Aqil, 2017, Exosomes for the enhanced tissue bioavailability and efficacy of curcumin, AAPS J., 19, 1691, 10.1208/s12248-017-0154-9 Liang, 2018, Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells, Int. J. Nanomedicine, 13, 585, 10.2147/IJN.S154458 Zhang, 2020, Exosome-delivered c-Met siRNA could reverse chemoresistance to cisplatin in gastric Cancer, Int. J. Nanomedicine Wang, 2018, Exosomes serve as nanoparticles to deliver Anti-miR-214 to reverse chemoresistance to cisplatin in gastric Cancer, Mol. Ther., 26, 774, 10.1016/j.ymthe.2018.01.001 Liang, 2020, Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer, J. Nanobiotechnology, 18, 10, 10.1186/s12951-019-0563-2 Schindler, 2019, Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency, PLoS One, 14, e0214545, 10.1371/journal.pone.0214545 Wan, 2013, 213 Burnett, 2012, RNA-based therapeutics: current progress and future prospects, Chem. Biol., 19, 60, 10.1016/j.chembiol.2011.12.008 Riley, 2017, Recent advances in nanomaterials for gene delivery—a review, Nanomaterials, 7, 10.3390/nano7050094 Housman, 2014, Drug resistance in cancer: an overview, Cancers, 6, 1769, 10.3390/cancers6031769 Ozasa, 2014, Significance of c-MET overexpression in cytotoxic anticancer drug-resistant small-cell lung cancer cells, Cancer Sci., 105, 1032, 10.1111/cas.12447 Nakajima, 1999, The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas, Cancer, 85, 1894, 10.1002/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2-J Kuniyasu, 1992, Frequent amplification of the c-met gene in scirrhous type stomach cancer, Biochem. Biophys. Res. Commun., 189, 227, 10.1016/0006-291X(92)91548-5 Tang, 2004, Overexpression of gastrin and c-met protein involved in human gastric carcinomas and intestinal metaplasia, Oncol. Rep., 11, 333 Zhang, 2018 Pham, 2018, Red blood cell extracellular vesicles as robust carriers of RNA-based therapeutics, Cell Stress., 2, 239, 10.15698/cst2018.09.155 Huang, 2019, Natural products for treating colorectal cancer: a mechanistic review, Biomed. Pharmacother., 117, 109142, 10.1016/j.biopha.2019.109142 Rawat, 2018, An overview of natural plant products in the treatment of hepatocellular carcinoma, Anticancer Agents Med. Chem., 18, 1838, 10.2174/1871520618666180604085612 Lipinski, 2000, Drug-like properties and the causes of poor solubility and poor permeability, J. Pharmacol. Toxicol. Methods, 44, 235, 10.1016/S1056-8719(00)00107-6 Xie, 2016, Nanotechnology for the delivery of phytochemicals in cancer therapy, Biotechnol. Adv., 34, 343, 10.1016/j.biotechadv.2016.04.002 Geraets, 2014, Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats, Part. Fibre Toxicol., 11, 30, 10.1186/1743-8977-11-30 Dicheva, 2016, Pharmacokinetics, tissue distribution and therapeutic effect of cationic thermosensitive liposomal doxorubicin upon mild hyperthermia, Pharm. Res., 33, 627, 10.1007/s11095-015-1815-y Sung, 2011, Subchronic inhalation toxicity of gold nanoparticles, Part. Fibre Toxicol., 8, 16, 10.1186/1743-8977-8-16 Chollet, 2002, Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes, The Journal of Gene Medicine: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications, 4, 84, 10.1002/jgm.237 Szebeni, 2012, Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome, Nanomed. Nanotechnol. Biol. Med., 8, 176, 10.1016/j.nano.2011.06.003 Adamo, 2004, Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma, Oral Oncol., 40, 525, 10.1016/j.oraloncology.2003.10.010 Molina, 2008, Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Pascucci, 2014, Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery, J. Control. Release, 192, 262, 10.1016/j.jconrel.2014.07.042 Coccè, 2019, In vitro anticancer activity of extracellular vesicles (EVs) secreted by gingival mesenchymal stromal cells primed with paclitaxel, Pharmaceutics, 11, 61, 10.3390/pharmaceutics11020061 Kim, 2016, Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells, Nanomed. Nanotechnol. Biol. Med., 12, 655, 10.1016/j.nano.2015.10.012 Kim, 2018, Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations, Nanomedicine, 14, 195, 10.1016/j.nano.2017.09.011 McGowan, 2017, Anthracycline chemotherapy and cardiotoxicity, Cardiovasc. Drugs Ther., 31, 63, 10.1007/s10557-016-6711-0 Thorn, 2011, Doxorubicin pathways: pharmacodynamics and adverse effects, Pharmacogenet. Genomics, 21, 440, 10.1097/FPC.0b013e32833ffb56 Rivankar, 2014, An overview of doxorubicin formulations in cancer therapy, J. Cancer Res. Ther., 10, 853, 10.4103/0973-1482.139267 Wang, 2019, Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence, BMC Urol., 19, 90, 10.1186/s12894-019-0530-0 Henriksen, 2018, Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention, Heart, 104, 971, 10.1136/heartjnl-2017-312103 Shafei, 2017, A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer, Biomed. Pharmacother., 95, 1209, 10.1016/j.biopha.2017.09.059 Sharma, 2005, Curcumin: the story so far, Eur. J. Cancer, 41, 1955, 10.1016/j.ejca.2005.05.009 Nabavi, 2018, Curcumin and melanoma: from chemistry to medicine, Nutr. Cancer, 70, 164, 10.1080/01635581.2018.1412485 Kasi, 2016, Molecular targets of curcumin for cancer therapy: an updated review, Tumour Biol., 37, 13017, 10.1007/s13277-016-5183-y Dona, 2012, Chemopreventive and chemotherapeutic potential of curcumin in breast Cancer, Curr. Drug Targets, 13, 1799, 10.2174/138945012804545632 Anand, 2007, Molecular bioavailability of curcumin: problems and promises, Mol. Pharm., 4, 807, 10.1021/mp700113r Mahmud, 2016, Long-circulating curcumin-loaded liposome formulations with high incorporation efficiency, stability and anticancer activity towards pancreatic adenocarcinoma cell lines in vitro, PLoS One, 11, e0167787, 10.1371/journal.pone.0167787 Mai, 2017, Electrospray biodegradable microcapsules loaded with curcumin for drug delivery systems with high bioactivity, RSC Adv., 7, 1724, 10.1039/C6RA25314H Ning, 2018, High encapsulation and localized delivery of curcumin from an injectable hydrogel, Mater. Sci. Eng. C, 83, 121, 10.1016/j.msec.2017.11.022 Sun, 2010, A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes, Mol. Ther., 18, 1606, 10.1038/mt.2010.105 Vashisht, 2017, Curcumin encapsulated in milk exosomes resists human digestion and possesses enhanced intestinal permeability in vitro, Appl. Biochem. Biotechnol., 183, 993, 10.1007/s12010-017-2478-4 Yang, 2019, Prevention and treatment effects of edible berries for three deadly diseases: cardiovascular disease, cancer and diabetes, Crit. Rev. Food Sci. Nutr., 59, 1903, 10.1080/10408398.2018.1432562 Bishayee, 2016, Potential benefits of edible berries in the management of Aerodigestive and gastrointestinal tract cancers: preclinical and clinical evidence, Crit. Rev. Food Sci. Nutr., 56, 1753, 10.1080/10408398.2014.982243 Seeram, 2008, Berry fruits for cancer prevention: current status and future prospects, J. Agric. Food Chem., 56, 630, 10.1021/jf072504n Lőrincz, 2014, Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes, J. Extracell. Vesicles, 3, 25465, 10.3402/jev.v3.25465 Park, 2018, The effect of storage temperature on the biological activity of extracellular vesicles for the complement system, Vitr. Cell. Dev. Biol. - Anim., 54 Zhou, 2006, Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery, Kidney Int., 69, 1471, 10.1038/sj.ki.5000273 Bosch, 2016, Trehalose prevents aggregation of exosomes and cryodamage, Sci. Rep., 6, 36162, 10.1038/srep36162 Allan, 1980, The isolation and characterization of 60 nm vesicles (’nanovesicles’) produced during ionophore A23187-induced budding of human erythrocytes, Biochem. J., 188, 881, 10.1042/bj1880881 Allan, 1989, Echinocytosis and microvesiculation of human erythrocytes induced by insertion of merocyanine 540 into the outer membrane leaflet, Biochim. Biophys. Acta, 986, 115, 10.1016/0005-2736(89)90279-4 Rychly, 2005, Infections associated with tumor necrosis Factor-α antagonists, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 25, 1181, 10.1592/phco.2005.25.9.1181 Riegert-Johnson, 2002, Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion, Inflamm. Bowel Dis., 8, 186, 10.1097/00054725-200205000-00005 Susa, 2019, Engineered extracellular vesicles as a reliable tool in Cancer nanomedicine, Cancers (Basel), 11, 10.3390/cancers11121979 Zhu, 2017, Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells, J. Extracell. Vesicles, 6, 1324730, 10.1080/20013078.2017.1324730 Nakamura, 2016, Exosomes promote ovarian Cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells, Mol. Cancer Res. Balaj, 2011, Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences, Nat. Commun., 2, 180, 10.1038/ncomms1180 Chen, 2011, Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs, J. Transl. Med., 9, 47, 10.1186/1479-5876-9-47 Szebeni, 2014, Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals, Mol. Immunol., 61, 163, 10.1016/j.molimm.2014.06.038 Lener, 2015, Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper, J. Extracell. Vesicles, 4, 30087, 10.3402/jev.v4.30087 Montaner-Tarbes, 2018, Targeted-pig trial on safety and immunogenicity of serum-derived extracellular vesicles enriched fractions obtained from Porcine Respiratory and Reproductive virus infections, Sci. Rep., 8, 17487, 10.1038/s41598-018-36141-5 Potz, 2018, Extracellular vesicle injection improves myocardial function and increases angiogenesis in a swine model of chronic ischemia, J. Am. Heart Assoc., 7, e008344, 10.1161/JAHA.117.008344 Keller, 2011, Body fluid derived exosomes as a novel template for clinical diagnostics, J. Transl. Med., 9, 86, 10.1186/1479-5876-9-86 Baassiri, 2020, Exosomal non coding RNA in LIQUID biopsies as a promising biomarker for colorectal Cancer, Int. J. Mol. Sci., 21, 10.3390/ijms21041398 Cui, 2018, Exosomes as a liquid biopsy for lung cancer, Lung Cancer, 116, 46, 10.1016/j.lungcan.2017.12.012 Halvaei, 2018, Exosomes in Cancer liquid biopsy: a focus on breast Cancer, Mol. Ther. €” Nucleic Acids, 10, 131, 10.1016/j.omtn.2017.11.014 Pisitkun, 2004, Identification and proteomic profiling of exosomes in human urine, Proc. Natl. Acad. Sci. U.S.A., 101, 13368, 10.1073/pnas.0403453101